Release of NY Asmussen Probe Delayed: The Blood-Horse 9/23/15

By Tom Precious The much-anticipated Sept. 24 release by New York regulators of their probe into the care of horses trained by Steve Asmussen is being delayed. More than 18 months after the People for the Ethical Treatment of Animals alleged widespread abuse of horses in Asmussen's care, the New York Gaming Commission on the

CHRB Commissioner’s Filly DQ’d From Stakes: The Blood-Horse 9/23/15

By Jeremy Balan California Horse Racing Board commissioner George Krikorian's Big Book has been disqualified from her victory in the July 25 Fleet Treat at Del Mar because of a test that showed elevated levels of acepromazine, which can be used as a tranquilizer in horses. Trained by Tim Yakteen, the 3-year-old daughter of Mr.

Ziadie Fighting Denial of License in Florida: Paulick Report 9/20/15

By Ray Paulick Trainer Kirk Ziadie is fighting an Aug. 26 decision by the Florida Division of Pari-Mutuel Wagering to deny his occupational license application because of what the regulatory agency said were three medication violations – two overages of phenylbutazone and one clenbuterol positive – earlier this year. Ziadie, who won at a 49

Regulators Step Up Push for Drug Uniformity: The Blood-Horse 9/16/15

By Tom LaMarra The Association of Racing Commissioners International is stepping up efforts to get state regulators to fully adopt the National Uniform Medication Program. ARCI chairman Mark Lamberth of the Arkansas State Racing Commission said Sept. 16 he is the process of forming a committee that will address implementation of equine medication reforms. ARCI

CHRB Moves Forward on Third-Party Lasix: The Blood-Horse 9/16/15

By Jeremy Balan Nearly a month after the California Horse Racing Board hit the brakes on third-party administration of furosemide in the state, the governing body spent just more than a minute to move the process along at a meeting Sept. 16 at Los Alamitos Race Course. The CHRB approved a motion to send the

Trainer Tom Amoss To Begin 45-Day Suspension Thursday: Paulick Report 9/15/15

By Paulick Report Staff Trainer Tom Amoss will begin a 45-day suspension imposed by the Indiana Horse Racing Commission on Thursday, Sept. 17. The suspension will run through the end of October, and include both days of the Breeders’ Cup. According to a report in the Daily Racing Form, the suspension dates to a 2011

Foundation Authorizes Two Lasix Studies: The Blood-Horse 9/15/15

By Blood-Horse Staff Two research projects designed to study the impact of furosemide on exercise-induced pulmonary hemorrhage will be conducted on behalf of the Grayson-Jockey Club Research Foundation, the organization said Sept. 15. The studies will examine the pathophysiology of EIPH, or bleeding in horses' lungs. The condition is currently treated with furosemide, also known

Status of KY Lasix-Free Regulation Uncertain: The Blood-Horse 9/10/15

By Ron Mitchell The Administrative Regulation Review Subcommittee of the Kentucky legislature has voted 6-2 to find a proposed regulation permitting racetracks the option of carding furosemide-free races "deficient." Furosemide, commonly known as Salix or Lasix, is a widely-used anti-diuretic medication. In a release, the Kentucky Horsemen's Benevolent and Protective Association said the 6-2 vote

CHRB Committee Advances New Lasix Proposal: The Blood-Horse 9/4/15

By Jeremy Balan The California Horse Racing Board Medication and Track Safety Committee took a step forward Sept. 4 regarding the potential employment of third-party furosemide administration in the state, but any change in procedures still likely won't occur until 2016. After the CHRB sent a proposal on third-party administration of furosemide, commonly known as

NYTHA To Acquire New Testing Equipment For NY Equine Drug…: NYTHA.com 9/1/15

Press Release The New York Thoroughbred Horsemen’s Association (NYTHA) today announced its commitment to acquire state-of-the-art testing equipment for the New York Equine Drug Testing and Research Program at Morrisville State College. The new equipment, a triple quadrupole mass spectrometer, will be used to screen for new drugs that are alleged to be used in

Learn About Our:

Who We Are:

Sign up to receive RMTC communications:

  • This field is hidden when viewing the form

Sign up to receive RMTC communications:

  • This field is hidden when viewing the form